{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T09:20:36Z","timestamp":1692696036224},"reference-count":12,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/etm.2016.3945","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T12:53:52Z","timestamp":1480596832000},"page":"269-272","source":"Crossref","is-referenced-by-count":2,"title":["Effects of low-dose tolvaptan on electrolyte abnormality and hemodynamic parameters in a liver cirrhosis-associated portopulmonary hypertension patient: A case report"],"prefix":"10.3892","volume":"13","author":[{"given":"Yoshito","family":"Ogihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimasa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"key20180108134731_b1-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"363","author":"Hoeper","year":"2004","journal-title":"Lancet"},{"key":"key20180108134731_b2-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semnephrol.2011.09.005","article-title":"Use of diuretics in heart failure and cirrhosis","volume":"31","author":"Schrier","year":"2011","journal-title":"Semin Nephrol"},{"key":"key20180108134731_b3-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccm.2006.11.004","article-title":"Portopulmonary hypertension","volume":"28","author":"Golbin","year":"2007","journal-title":"Clin Chest Med"},{"key":"key20180108134731_b4-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1177\/030006051204000637","article-title":"ASCITES Clinical Pharmacology Group: The pharmacokinetics and pharmacodynamics of tolvaptan in patients with liver cirrhosis with insufficient response to conventional diuretics: A multicentre, double-blind, parallel-group, phase III study","volume":"40","author":"Sakaida","year":"2012","journal-title":"J Int Med Res"},{"key":"key20180108134731_b5-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/hepr.12098","article-title":"Ascites-Doubleblind Study Group: Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial","volume":"44","author":"Sakaida","year":"2014","journal-title":"Hepatol Res"},{"key":"key20180108134731_b6-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/hepr.12099","article-title":"ASCITES Dose-Finding Trial Group: Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial","volume":"44","author":"Okita","year":"2014","journal-title":"Hepatol Res"},{"key":"key20180108134731_b7-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"ESC Committee for Practice Guidelines (CPG): Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"key20180108134731_b8-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"key20180108134731_b9-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","article-title":"Hyponatremia in cirrhosis: From pathogenesis to treatment","volume":"28","author":"Gin\u00e9s","year":"1998","journal-title":"Hepatology"},{"key":"key20180108134731_b10-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0016-5085(83)90198-1","article-title":"Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system","volume":"84","author":"P\u00e9rez-Ayuso","year":"1983","journal-title":"Gastroenterology"},{"key":"key20180108134731_b11-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/eurjhf\/hfs173","article-title":"Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: A pilot study","volume":"15","author":"Maron","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key20180108134731_b12-etm-0-0-3945","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","article-title":"Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension","volume":"304","author":"Preston","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3945\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T04:39:44Z","timestamp":1568608784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,1]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/etm.2016.3945"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3945","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}